Long Xiang Cao
Chairman chez HUBEI JUMPCAN PHARMACEUTICAL CO., LTD.
Fortune : 2 919 M $ au 31/03/2024
Profil
Long Xiang Cao occupe le poste de président de Hubei Jumpcan Pharmaceutical Co., Ltd. et de président et directeur général de Jumpcan Pharmaceutical Co. Ltd. (une filiale de Hubei Jumpcan Pharmaceutical Co., Ltd.). Il siège également au conseil d'administration de Jiangsu Baota Cement Co, Ltd.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/09/2023 | 563 595 818 ( 61,54% ) | 2 919 M $ | 31/03/2024 |
Postes actifs de Long Xiang Cao
| Sociétés | Poste | Début |
|---|---|---|
| HUBEI JUMPCAN PHARMACEUTICAL CO., LTD. | Chairman | 10/03/2014 |
| Jiangsu Baota Cement Co., Ltd. | Director/Board Member | 25/12/2001 |
Jumpcan Pharmaceutical Co. Ltd.
 Jumpcan Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Hubei Jumpcan Pharmaceutical Co., Ltd., Jumpcan Pharmaceutical Co. Ltd. is a pharmaceutical company based in Taixing, China. The Chinese company offers a range of products including mouthwash, cough medicine, and pain relief ointments. The CEO of the private company is Long Xiang Cao. Jumpcan Pharmaceutical Co. was acquired by Hubei Jumpcan Pharmaceutical Co., Ltd. from Jiangsu Jichuan Holdings Group Co. Ltd. on December 20, 2013 for $911.88 million. | Chief Executive Officer | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| HUBEI JUMPCAN PHARMACEUTICAL CO., LTD. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Jumpcan Pharmaceutical Co. Ltd.
Jumpcan Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Hubei Jumpcan Pharmaceutical Co., Ltd., Jumpcan Pharmaceutical Co. Ltd. is a pharmaceutical company based in Taixing, China. The Chinese company offers a range of products including mouthwash, cough medicine, and pain relief ointments. The CEO of the private company is Long Xiang Cao. Jumpcan Pharmaceutical Co. was acquired by Hubei Jumpcan Pharmaceutical Co., Ltd. from Jiangsu Jichuan Holdings Group Co. Ltd. on December 20, 2013 for $911.88 million. | Health Technology |
| Jiangsu Baota Cement Co., Ltd. |
